CClinicalTrials.gg
CompletedNCT07468253ASYMECONEUpdated Mar 12, 2026

Risk Factors for Inter-eye Asymmetry in Keratoconus Severity

An observational study in Keratoconus, sponsored by Centre Hospitalier Régional Metz-Thionville. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Centre Hospitalier Régional Metz-Thionville · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
154
Ages
18 Years and older
Sex
All
01

Study summary

Observational study comparing patients with inter-eye asymmetric keratoconus with patients with inter-eye symmetric keratoconus.

Read the detailed description

Detailed description: Keratoconus is a condition resulting in corneal thinning and visual impairment due to irregular astigmatism. Most cases are bilateral, although the severity is often asymmetric between both eyes. The aim of our study is to examine risk factors for inter-eye asymmetry in terms of severity in patients with a confirmed diagnosis of keratoconus. Patients were reviewed for keratoconus staging for each eye according to the Amsler-Krumeich classification to define asymmetry and separated in groups according to the laterality of the worst eye and in a group where both eyes were symmetric in terms of asymmetry. A multivariate logistic regression was performed on various risk factors to explore keratoconus inter-eye asymmetry.

02

Conditions studied

  • Keratoconus

Browse trials for

Keywords

  • keratoconus
  • Asymmetry
03

In context

Keratoconus

307 studies on the registry are indexed under Keratoconus; 56 are open to participants now.

This study's enrollment of 154 is above the median of 130 across 94 observational studies indexed under Keratoconus.

Browse Keratoconus studies →

Lead sponsor

Centre Hospitalier Régional Metz-Thionville is the lead sponsor of 118 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients presenting to the attending ophthalmologist during the study period with previously diagnosed unilateral or bilateral keratoconus or patients newly diagnosed with unilateral or bilateral keratoconus during the study period.

Inclusion criteria

  • Patients presenting to the attending ophthalmologist during the study period with previously diagnosed unilateral or bilateral keratoconus
  • Patients newly diagnosed with unilateral or bilateral keratoconus during the study period.

Exclusion criteria

Exclusion Criteria:

  • Previous corneal surgery
  • Previous corneal crosslinking
  • Previous keratoplasty
  • Previous placement of intrastromal corneal rings
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
154 participants (actual)
Patient registry
No

Groups and cohorts

  • cohort of Patients with keratoconus

    Patients presenting to the attending ophthalmologist during the study period with previously diagnosed unilateral or bilateral keratoconus or (ii) patients newly diagnosed with unilateral or bilateral keratoconus during the study period.

    Behavioral: Questionnaire

Interventions

  • BehavioralQuestionnaire

    Questionnaire about eye rubbing habits

06

What researchers measure

Primary outcomes

  1. Risk factors for inter-eye keratoconus asymmetry in terms of severity

    Logistic regression

    Time frame: Day 1

07

Study locations

1 site
  • CHR Metz-Thionville Hopital de Mercy
    Metz, 57085, France
08

References and documents

Individual participant data

Plan to share: No — According to French law and the guidelines of the French Data Protection Authority (CNIL), individual participant data cannot be publicly shared. However, study findings will be disseminated through peer-reviewed publications and presentations at scientific conferences.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07468253
Lead sponsor
Centre Hospitalier Régional Metz-Thionville
Responsible party
Sponsor
First posted
Mar 12, 2026
Start date
Jan 1, 2020
Primary completion
Feb 27, 2023
Completion
Feb 27, 2023
Last update
Mar 12, 2026

Study contacts

Jean-Marc PERONE, MD
principal investigator · CHR Metz-Thionville Hopital de Mercy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion